VMAT2 Inhibitors - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. VMAT2 Inhibitors Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. VMAT2 Inhibitors Market Restraints
Table 3. VMAT2 Inhibitors Market Trends
Table 4. VMAT2 Inhibitors Industry Policy
Table 5. Global VMAT2 Inhibitors Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global VMAT2 Inhibitors Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global VMAT2 Inhibitors Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global VMAT2 Inhibitors Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global VMAT2 Inhibitors Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global VMAT2 Inhibitors Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global VMAT2 Inhibitors Mergers & Acquisitions, Expansion Plans
Table 12. Global VMAT2 Inhibitors Manufacturers Product Type
Table 13. Head Office and VMAT2 Inhibitors Production Site of Key Manufacturer
Table 14. VMAT2 Inhibitors Capacity of Major Manufacturers and Future Plan
Table 15. China VMAT2 Inhibitors Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China VMAT2 Inhibitors Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China VMAT2 Inhibitors Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global VMAT2 Inhibitors Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global VMAT2 Inhibitors Production by Region, 2018-2023, (K Units)
Table 20. Global VMAT2 Inhibitors Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of VMAT2 Inhibitors Upstream (Raw Materials)
Table 22. Global VMAT2 Inhibitors Typical Customers
Table 23. VMAT2 Inhibitors Typical Distributors
Table 24. By Type, Global VMAT2 Inhibitors Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global VMAT2 Inhibitors Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global VMAT2 Inhibitors Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global VMAT2 Inhibitors Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global VMAT2 Inhibitors Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global VMAT2 Inhibitors Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global VMAT2 Inhibitors Consumption Value Market Share, 2018-2029
Table 32. By Country, Global VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global VMAT2 Inhibitors Sales Quantity Market Share, 2018-2029
Table 34. Neurocrine Biosciences, Inc Company Information, Head Office, Market Area, and Industry Position
Table 35. Neurocrine Biosciences, Inc VMAT2 Inhibitors Models, Specifications, and Application
Table 36. Neurocrine Biosciences, Inc VMAT2 Inhibitors Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Neurocrine Biosciences, Inc Company Profile and Main Business
Table 38. Neurocrine Biosciences, Inc Recent Developments
Table 39. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
Table 40. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Models, Specifications, and Application
Table 41. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 43. Teva Pharmaceutical Industries Ltd Recent Developments
Table 44. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
Table 45. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Models, Specifications, and Application
Table 46. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 48. Sun Pharmaceutical Industries Ltd Recent Developments
Table 49. Hikma Pharmaceuticals plc Company Information, Head Office, Market Area, and Industry Position
Table 50. Hikma Pharmaceuticals plc VMAT2 Inhibitors Models, Specifications, and Application
Table 51. Hikma Pharmaceuticals plc VMAT2 Inhibitors Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Hikma Pharmaceuticals plc Company Profile and Main Business
Table 53. Hikma Pharmaceuticals plc Recent Developments
Table 54. Hetero Company Information, Head Office, Market Area, and Industry Position
Table 55. Hetero VMAT2 Inhibitors Models, Specifications, and Application
Table 56. Hetero VMAT2 Inhibitors Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Hetero Company Profile and Main Business
Table 58. Hetero Recent Developments
Table 59. Bausch Health Companies Inc Company Information, Head Office, Market Area, and Industry Position
Table 60. Bausch Health Companies Inc VMAT2 Inhibitors Models, Specifications, and Application
Table 61. Bausch Health Companies Inc VMAT2 Inhibitors Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Bausch Health Companies Inc Company Profile and Main Business
Table 63. Bausch Health Companies Inc Recent Developments
Table 64. Dr. Reddy's Laboratories Ltd Company Information, Head Office, Market Area, and Industry Position
Table 65. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Models, Specifications, and Application
Table 66. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Dr. Reddy's Laboratories Ltd Company Profile and Main Business
Table 68. Dr. Reddy's Laboratories Ltd Recent Developments
Table 69. Piramal Pharma Solution Company Information, Head Office, Market Area, and Industry Position
Table 70. Piramal Pharma Solution VMAT2 Inhibitors Models, Specifications, and Application
Table 71. Piramal Pharma Solution VMAT2 Inhibitors Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Piramal Pharma Solution Company Profile and Main Business
Table 73. Piramal Pharma Solution Recent Developments
Table 74. Lupin Company Information, Head Office, Market Area, and Industry Position
Table 75. Lupin VMAT2 Inhibitors Models, Specifications, and Application
Table 76. Lupin VMAT2 Inhibitors Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Lupin Company Profile and Main Business
Table 78. Lupin Recent Developments
Table 79. Luye Pharma Group Company Information, Head Office, Market Area, and Industry Position
Table 80. Luye Pharma Group VMAT2 Inhibitors Models, Specifications, and Application
Table 81. Luye Pharma Group VMAT2 Inhibitors Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Luye Pharma Group Company Profile and Main Business
Table 83. Luye Pharma Group Recent Developments
List of Figures
Figure 1. VMAT2 Inhibitors Picture
Figure 2. Global VMAT2 Inhibitors Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global VMAT2 Inhibitors Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global VMAT2 Inhibitors Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China VMAT2 Inhibitors Consumption Value, (US$ million) & (2018-2029)
Figure 6. China VMAT2 Inhibitors Sales Quantity (K Units) & (2018-2029)
Figure 7. China VMAT2 Inhibitors Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China VMAT2 Inhibitors Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China VMAT2 Inhibitors Market Share of Global, 2018-2029
Figure 10. Global VMAT2 Inhibitors Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China VMAT2 Inhibitors Key Participants, Market Share, 2022
Figure 12. Global VMAT2 Inhibitors Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global VMAT2 Inhibitors Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global VMAT2 Inhibitors Production Market Share & Forecast by Region, 2018-2029
Figure 15. VMAT2 Inhibitors Industry Chain
Figure 16. VMAT2 Inhibitors Procurement Model
Figure 17. VMAT2 Inhibitors Sales Model
Figure 18. VMAT2 Inhibitors Sales Channels, Direct Sales, and Distribution
Figure 19. Tetrabenazine
Figure 20. Valbenazine
Figure 21. Other
Figure 22. By Type, Global VMAT2 Inhibitors Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global VMAT2 Inhibitors Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global VMAT2 Inhibitors Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global VMAT2 Inhibitors Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Huntington's Disease
Figure 28. Tardive Dyskinesia
Figure 29. Other
Figure 30. By Application, Global VMAT2 Inhibitors Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global VMAT2 Inhibitors Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Figure 33. By Application, Global VMAT2 Inhibitors Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global VMAT2 Inhibitors Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global VMAT2 Inhibitors Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global VMAT2 Inhibitors Sales Quantity Market Share, 2018-2029
Figure 37. North America VMAT2 Inhibitors Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America VMAT2 Inhibitors Consumption Value Market Share, 2022
Figure 39. Europe VMAT2 Inhibitors Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe VMAT2 Inhibitors Consumption Value Market Share, 2022
Figure 41. Asia Pacific VMAT2 Inhibitors Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific VMAT2 Inhibitors Consumption Value Market Share, 2022
Figure 43. South America VMAT2 Inhibitors Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America VMAT2 Inhibitors Consumption Value Market Share, 2022
Figure 45. Middle East & Africa VMAT2 Inhibitors Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Figure 47. By Type, U.S. VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, Europe VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 52. China VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, China VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, Japan VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, South Korea VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, Southeast Asia VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 64. India VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, India VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa VMAT2 Inhibitors Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, Middle East & Africa VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa VMAT2 Inhibitors Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets